Filing Flows › Molina Healthcare (MOH) › Stock forecast & fair value
Molina Healthcare (MOH) stock forecast and fair value
Molina Healthcare (MOH) trades at $216.64. 17 analysts' median price target is $222.00 (+2%), from $163.00 to $266.00. Across 7 valuation methods the middle fair value is $193.64 (-11%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| Residual income | $56.89 | $59.17 | $61.60 | -73% |
| P/B vs ROE (insurer peers) | $0.00 | $99.48 | $215.64 | -54% |
| Analysts' price targets | $163.00 | $219.53 | $266.00 | +1% |
| Our model (Rotation forecast) | $119.78 | $193.64 | $313.05 | -11% |
| Shareholder yield (dividends + buybacks) | $435.35 | $557.24 | $773.92 | +157% |
| Stage-weighted value (financial (bank / insurer)) | $28.45 | $79.33 | $138.62 | -63% |
| Combined forecast (3 months) | $178.45 | $226.33 | $280.17 | +4% |
Molina Healthcare's latest quarter
Molina Healthcare, Q3 2026: revenue $11.1B (-3% year over year), operating margin 1.0%, net earnings $38.0M, operating cash flow −$159M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for MOH stock?
The median of 17 analysts' 12-month targets is $222.00, +2% from $216.64; the range is $163.00 to $266.00. The average rating is hold.
What is Molina Healthcare's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $59.17 and $557.24, with a middle value of $193.64 against a price of $216.64. Each method's assumptions are on the page.
Does Molina Healthcare usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is MOH stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.